Buy One Get One free -Llimited Time Offer X
Elipran 40 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Migraine.
Medical history of the patient along with age and gender determines the dosage of Elipran 40 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Elipran 40 Tablet can also lead to other problems, which have been listed below. Such side effects of Elipran 40 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Elipran 40 Tablet is Moderate for pregnant women and Moderate for women who are breastfeeding. It is important to know if Elipran 40 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Elipran 40 Tablet related warnings section.
Individuals suffering from medical conditions like Drug Allergy, Liver Disease, Heart Disease must refrain from the use of Elipran 40 Tablet since this can cause severe adverse effects. The section on Elipran 40 Tablet contraindications lists all such conditions.
Drug reaction of Elipran 40 Tablet with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Elipran 40 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Elipran 40 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Elipran 40 Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Elipran. It is best to stop taking Elipran immediately and inform your doctor if you notice any discomfort.
Is the use of Elipran 40 Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Elipran. If you see any side effects, stop taking Elipran immediately and talk to your doctor. Take Elipran again, only after your doctor's advice.
What is the effect of Elipran 40 Tablet on the Kidneys?
Elipran rarely affects the kidneys.
What is the effect of Elipran 40 Tablet on the Liver?
Elipran has very mild side effects on the liver.
What is the effect of Elipran 40 Tablet on the Heart?
Elipran may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Elipran 40 Tablet unless your doctor advises you to do so -
Is this Elipran 40 Tablet habit forming or addictive?
Forming a habit of Elipran 40 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Elipran 40 Tablet. So it is best to avoid driving.
Is it safe?
Yes, but consume Elipran 40 Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, Elipran 40 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Elipran 40 Tablet
Information is not available on the interaction of any foods with Elipran 40 Tablet, due to a lack of research on this.
Interaction between Alcohol and Elipran 40 Tablet
It is difficult to say anything about the effect of Elipran 40 Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Relpax® (eletriptan hydrobromide)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 91